COVID-19的血管本质
荷兰国家公共卫生研究所发布报告,提出COVID-19是一种血管疾病的新概念,认为症状和诊断检查不能用肺通气受损解释,而是由SARS病毒损伤微血管导致肺及全身器官微血栓形成,进而引发大血栓和栓塞,因此建议抗凝预防、密切实验室和CT影像监测及早期抗凝治疗。
要点
- COVID-19症状与诊断检查不能用肺通气受损解释,影像和病理证实为肺灌注障碍并累及全身器官。
- SARS 1和SARS 2病毒损伤微血管,导致肺毛细血管及器官微血栓形成,进而引发大血栓和栓塞。
- 荷兰国家公共卫生研究所报告建议抗凝预防、密切实验室和CT影像监测及早期抗凝治疗。
关键影像表现/征象
- 影像和病理检查证实COVID-19存在肺灌注障碍,且可累及全身器官。
- SARS 1和SARS 2病毒损伤微血管,引起肺毛细血管及器官微血栓形成,导致大血栓和栓塞。
临床应用与阅片要点
- 荷兰国家公共卫生研究所报告提出COVID-19血管疾病新概念,并据此给出诊断、预防和治疗血栓栓塞并发症的指导。
- 报告指出抗凝预防、密切实验室和CT影像监测及早期抗凝治疗有指征。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A potential link between mortality, D-dimer values and a prothrombotic syndrome has been reported in COVID-19 patients. The National Institute for Public Health of the Netherlands published a report for guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19 with a new vascular disease concept. The analysis of all available current medical, laboratory and imaging data on COVID-19 confirms that symptoms and diagnostic tests can not be explained by impaired pulmonary ventilation. Further imaging and pathological investigations confirm that the COVID-19 syndrome is explained by perfusion disturbances first in the lung, but consecutively in all organs of the body. Damage of the microvasculature by SARS 1 and SARS 2 (COVID-19) viruses causes microthrombotic changes in the pulmonary capillaries and organs leading to macrothrombosis and emboli. Therefore anticoagulant profylaxis, close lab and CT imaging monitoring and early anticoagulant therapy are indicated.
引用
- Oudkerk M, Kuijpers D, Oudkerk SF, et al. The vascular nature of COVID-19. Br J Radiol. 2020. PMID: 32735457. doi:10.1259/bjr.20200718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。